ARCHIVES

Biotech Organization Endorses Measures On Orphan Drug Act

This article is from The Cancer Letter archive.

Vol. 20 No. 13 | April 1, 1994

Download PDF Visit The Full Archive

Related Articles

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996

Deparle Leaves HCFA; Speyer Promoted At NYU Center.

September 15, 2000

Health Organizations: ACS Advises annual Prostate Screening for some Younger Men

June 20, 1997

Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says

November 29, 1996

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

March 10, 1989

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997